Einstein Research

Research News

New England Journal of Medicine Publishes Initial Data from TAILORx Breast Cancer Trial

New England Journal of Medicine Publishes Initial Data from TAILORx Breast Cancer Trial



September 28, 2015—VIENNA and PHILADELPHIA and REDWOOD CITY, Calif.)—Initial results were announced today from the Trial Assigning Individualized Options for Treatment (Rx), or TAILORx, a multi-center prospectively conducted trial of more than 10,000 women with early stage breast cancer sponsored by the National Cancer ...read more

Other Top Stories

Microbiome Implicated in Sickle Cell Disease — But Antibiotics Can Counter Its Effects

Severe Headache in Pregnant Women: When to Worry

Research Round-Up

INI1-road against HIV—More than 35 million individuals worldwide are living with HIV, and drug resistance to various available treatments is prevalent because of the virus’ extremely high mutation rate. The National Institute of General Medical Services has awarded Ganjam Kalpana, Ph.D., nearly $1.3 million  over four years to study potential drug targets for HIV and develop inhibitors for these... read more


Preventing HIV Infection—The NIH has awarded Viraj Patel, M.D., MPH a career development award of nearly $1 million over five years to develop tools for preventing HIV infection in young men of color who have sex with men (YMCSM). As this population has the highest rates of new HIV infections in the U.S., Dr. Patel plans to partner with YMCSM peer... read more


Identifying New Treatment Targets—The National Institute of Allergy and Infectious Disease has awarded Felipe Diaz-Griffero, Ph.D. $2.7 million over five years, to study the molecular mechanisms that govern HIV-1 viral capsid “uncoating”—a key step allowing HIV-1 (the virus that causes AIDS) to infect cells. Dr. Diaz-Griffero has identified the capsid as a novel target to prevent HIV-1 infection and... read more

view all

Investigator Resources


view all Investigator Resources >>

Research Spotlight

The IUD Option

The IUD Option

Two recent studies from Einstein-Montefiore faculty spotlight the benefits of the intrauterine device (IUD), an extremely effective contraceptive that is underused by American women.

read more


Einstein Experts

Dr. Harry Shamoon

Dr. Harry Shamoon
  • Translational research
  • Clinical research

Dr. Shamoon represents Einstein and Montefiore Medical Center in the NIH’s Clinical and Translational Science Award Consortium, an elite group ...read more

view Einstein Expert list